These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 16211296

  • 1. Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.
    Tanaka S, Kobayashi I, Utsuki S, Oka H, Yasui Y, Fujii K.
    Oncol Rep; 2005 Nov; 14(5):1275-80. PubMed ID: 16211296
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea.
    Sato K, Kitajima Y, Nakagawachi T, Soejima H, Miyoshi A, Koga Y, Miyazaki K.
    Oncol Rep; 2005 May; 13(5):899-906. PubMed ID: 15809756
    [Abstract] [Full Text] [Related]

  • 3. O6-methylguanine-DNA methyltranspherase gene expression in gliomas by means of real-time quantitative RT-PCR and clinical response to nitrosoureas.
    Tanaka S, Kobayashi I, Utsuki S, Oka H, Fujii K, Watanabe T, Nagashima T, Hori T.
    Int J Cancer; 2003 Jan 01; 103(1):67-72. PubMed ID: 12455055
    [Abstract] [Full Text] [Related]

  • 4. Individual adjuvant therapy for malignant gliomas based on O6-methylguanine-DNA methyltransferase messenger RNA quantitation by real-time reverse-transcription polymerase chain-reaction.
    Tanaka S, Akimoto J, Kobayashi I, Oka H, Ujiie H.
    Oncol Rep; 2008 Jul 01; 20(1):165-71. PubMed ID: 18575733
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea resistance of human brain tumors.
    Nagane M, Asai A, Shibui S, Nomura K, Matsutani M, Kuchino Y.
    Jpn J Clin Oncol; 1992 Jun 01; 22(3):143-9. PubMed ID: 1518162
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
    Brell M, Tortosa A, Verger E, Gil JM, Viñolas N, Villá S, Acebes JJ, Caral L, Pujol T, Ferrer I, Ribalta T, Graus F.
    Clin Cancer Res; 2005 Jul 15; 11(14):5167-74. PubMed ID: 16033832
    [Abstract] [Full Text] [Related]

  • 8. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
    Sasai K, Nodagashira M, Nishihara H, Aoyanagi E, Wang L, Katoh M, Murata J, Ozaki Y, Ito T, Fujimoto S, Kaneko S, Nagashima K, Tanaka S.
    Am J Surg Pathol; 2008 Aug 15; 32(8):1220-7. PubMed ID: 18580490
    [Abstract] [Full Text] [Related]

  • 9. Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin.
    Park CK, Park SH, Lee SH, Kim CY, Kim DW, Paek SH, Kim DG, Heo DS, Kim IH, Jung HW.
    Neuropathology; 2009 Aug 15; 29(4):443-9. PubMed ID: 19170894
    [Abstract] [Full Text] [Related]

  • 10. Elevated expression of DNA polymerase beta gene in glioma cell lines with acquired resistance to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea.
    Gomi A, Shinoda S, Sakai R, Hirai H, Ozawa K, Masuzawa T.
    Biochem Biophys Res Commun; 1996 Oct 14; 227(2):558-63. PubMed ID: 8878552
    [Abstract] [Full Text] [Related]

  • 11. O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy.
    Silber JR, Blank A, Bobola MS, Ghatan S, Kolstoe DD, Berger MS.
    Clin Cancer Res; 1999 Apr 14; 5(4):807-14. PubMed ID: 10213216
    [Abstract] [Full Text] [Related]

  • 12. Adenoviral transfer of antisenses or ribozyme to O6-methylguanine-DNA methyltransferase mRNA in brain-tumor model resistant to chloroethyl-nitrosourea.
    Manome Y, Yoshinaga H, Watanabe M, Ohno T.
    Anticancer Res; 2002 Apr 14; 22(4):2029-36. PubMed ID: 12174880
    [Abstract] [Full Text] [Related]

  • 13. Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum.
    Ma Y, Yuan RQ, Fan S, Hu C, Goldberg ID, Laterra JJ, Rosen EM.
    Anticancer Drugs; 2006 Aug 14; 17(7):733-51. PubMed ID: 16926624
    [Abstract] [Full Text] [Related]

  • 14. Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes.
    Tanaka S, Kamitani H, Amin MR, Watanabe T, Oka H, Fujii K, Nagashima T, Hori T.
    J Neurooncol; 2000 Aug 14; 46(2):157-71. PubMed ID: 10894369
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
    Ushio Y, Abe H, Suzuki J, Tanaka R, Kitamura K, Miwa T, Matsutani M, Takeuchi K, Takakura K, Nomura K.
    No To Shinkei; 1985 Oct 14; 37(10):999-1006. PubMed ID: 3000412
    [Abstract] [Full Text] [Related]

  • 16. Is the absolute value of O(6)-methylguanine-DNA methyltransferase gene messenger RNA a prognostic factor, and does it predict the results of treatment of glioblastoma with temozolomide?
    Tanaka S, Akimoto J, Narita Y, Oka H, Tashiro T.
    J Neurosurg; 2014 Oct 14; 121(4):818-26. PubMed ID: 25105699
    [Abstract] [Full Text] [Related]

  • 17. Quantitation of O6-methylguanine-DNA methyltransferase gene messenger RNA in gliomas by means of real-time RT-PCR and clinical response to nitrosoureas.
    Tanaka S, Oka H, Fujii K, Watanabe K, Nagao K, Kakimoto A.
    Cell Mol Neurobiol; 2005 Sep 14; 25(6):1067-71. PubMed ID: 16392037
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Circumvention of ACNU-resistance in rat glioma cells by pretreatment with O6-methylguanine].
    Mineura K, Fushimi S, Sasaki J, Sasajima H, Ishino Y, Kowada M.
    Gan To Kagaku Ryoho; 1989 Feb 14; 16(2):259-62. PubMed ID: 2919893
    [Abstract] [Full Text] [Related]

  • 20. Relationship between O6-methylguanine-DNA methyltransferase levels and clinical response induced by chloroethylnitrosourea therapy in glioma patients.
    Chen ZP, Yarosh D, Garcia Y, Tampieri D, Mohr G, Malapetsa A, Langleben A, Panasci LC.
    Can J Neurol Sci; 1999 May 14; 26(2):104-9. PubMed ID: 10352868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.